In the wave of digital transformation in the pharmaceutical industry, a traditional Chinese medicine enterprise rooted in the Eyu region, "Youyoucao Eyu," is attempting to carve out a path. This company, which started with the cultivation and primary processing of Chinese medicinal herbs, has undergone a transformation from "passively going online" to "actively building its own network" over the past three years. Its approach is not simply about opening an e-commerce store, but rather attempting to embed internet genes into every link from planting bases to terminal pharmacies, providing a valuable case study for the digital survival of regional pharmaceutical companies.
The starting point of Youyoucao Eyu's transformation was not glamorous. In 2021, when leading pharmaceutical companies were deploying online consultations and DTP pharmacies, this company, with annual revenue just exceeding 500 million yuan, was still struggling under the price pressures imposed by traditional distributors. The then general manager stated bluntly at an industry conference: "We hold the authentic medicinal herbs of the Shennongjia and Wuling Mountains, yet we don't even have a direct sales channel." The turning point came in early 2022 when a mountain fire in Enshi, Hubei, unexpectedly exposed the fragility of its supply chain—due to the lack of a digital dispatch system, the allocation of rescue supplies and medicinal materials was delayed by a full three days. This crisis became the "catalyst" for the company's internal push towards digitalization.
Unlike most companies that choose to partner with third-party platforms, Youyoucao Eyu opted for a heavier path: building its own digital platform, the "Eyu Yaotong." This platform is not merely a B2B marketplace; it integrates over 2,000 upstream herb farmers, 3 midstream processing plants for decoction pieces, and more than 800 downstream clinics and pharmacies into a closed data loop. At the planting base in Fengjie, Chongqing, reporters observed that herb farmers simply need to scan a QR code with their smartphones to complete the full traceability process from harvesting to quality inspection. This "direct origin connection" model has reduced the circulation costs of core varieties such as licorice and codonopsis by 18%. More importantly, it has given the company its first real control over terminal pricing.
However, the internet transformation has not been smooth sailing. In 2023, Youyoucao Eyu attempted to mimic internet companies by launching an "O2O medicine delivery" service, but quickly discovered that the logistics costs and average order values in county-level markets were simply not proportional. The project lead admitted during a review with reporters: "We made a mistake of 'acclimatization failure.' The Eyu region is mountainous, and the average delivery cost per order is 2.3 times that of the plains." This setback made management realize that the digitalization of regional pharmaceutical companies must focus on "service radius" and do less. Consequently, they discontinued the C-end business and pivoted to deeply cultivate the "smart Chinese medicine pharmacy" scenario—providing AI-assisted prescription support and decoction delivery services for primary-level clinics. This adjustment unexpectedly aligned with the policy direction of the National Administration of Traditional Chinese Medicine to enhance primary-level TCM service capabilities.
Currently, Youyoucao Eyu's internet transformation has entered deep waters. The Q1 2024 financial report shows that its online business (including B2B matching and smart pharmacy service fees) contributed 22% of total revenue. Although the proportion is not high, the gross margin is 11 percentage points higher than that of its traditional business. More critically, the transaction data accumulated on the platform has guided the company in adjusting the variety structure at the planting end. For example, the system detected a surge in demand for cough and wheezing prescriptions in the Wanzhou area of Chongqing, prompting timely guidance for farmers to increase the cultivation of aster and tussilago, thereby avoiding oversupply and unsold inventory from blind planting.
In the eyes of industry observers, the case of Youyoucao Eyu reflects the common dilemmas and potential solutions for small and medium-sized pharmaceutical companies in China. On one hand, they cannot afford to burn cash building extensive digital ecosystems like large pharmaceutical giants; on the other hand, they hold two "trump cards": geographically indicated medicinal herbs and local medical resources. The practice of Youyoucao Eyu demonstrates that the digitalization of regional pharmaceutical companies need not pursue a "grand and comprehensive" approach, but rather, within a specific geographic radius, use digital tools to reconstruct the chain of trust. As a saying within the company goes: "The internet is not a panacea, but it can help the good herbs from the Wuling Mountains leave the mountains in a more dignified way."